Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -463.6% | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 2.2 | n/a |
Pr/Book | 0.8 |
Latest | F'cast | |
---|---|---|
Revenue | -32.1% | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Sep-18 | 1.08 | (7.29) | (16.08)p | n/a | n/a | n/a | n/a | 0.0% |
30-Sep-19 | 1.93 | (6.24) | (13.04)p | n/a | n/a | n/a | n/a | 0.0% |
30-Sep-20 | 1.96 | (5.01) | (9.87)p | n/a | n/a | n/a | n/a | 0.0% |
30-Sep-21 | 1.74 | (5.91) | (10.84)p | n/a | n/a | n/a | n/a | 0.0% |
30-Sep-22 | 1.18 | (5.50) | (9.19)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Preliminary Results | 27-Jan-2023 | 07:00 | RNS |
Employee Share Scheme, Directors Dealings and TVR | 04-Jan-2023 | 11:23 | RNS |
Trading Statement | 15-Dec-2022 | 07:00 | RNS |
Actavis buys speciality drugmaker Forest Labs fo... | 19-Feb-2014 | Guardian |
Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
04-Jan-23 | Buy | Richard Steele | 1.50p | 38,887 | £583.30 |
04-Jan-23 | Buy | Stephen Davidson | 1.50p | 24,435 | £366.52 |
04-Jan-23 | Buy | Steve Bennetts | 1.50p | 79,771 | £1,196.56 |
Currency | UK Pounds |
Share Price | 1.25p |
Change Today | 0.029p |
% Change | 2.35 % |
52 Week High | 16.00 |
52 Week Low | 1.10 |
Volume | 0 |
Shares Issued | 214.97m |
Market Cap | £2.70m |
RiskGrade | 241 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
You are here: research